日批在线视频_内射毛片内射国产夫妻_亚洲三级小视频_在线观看亚洲大片短视频_女性向h片资源在线观看_亚洲最大网

US EUROPE AFRICA ASIA 中文
Business / Industries

Stem cells offer ray of hope for healthy future

By Alfred Romann in Seoul For China Daily (China Daily) Updated: 2014-06-23 07:08

Regenerative medicine sector needs more financial support from private investors

One of the most important and innovative pharmaceutical companies in Asia has its headquarters in a busy neighborhood of Seoul, nestled between insurance companies and banks, and not far from Seoul National University.

Medipost Co Ltd, launched in 2000 to research and develop stem cell and regenerative medicine products, has emerged as a leader in the space, both regionally and globally. It took a dozen years for the company to launch its first product commercially: Cartistem used to treat repair cartilages in the knee.

Between its founding and its first product launch, Medipost issued new shares six times and split its stock once. It generated some further revenue, mostly by storing umbilical cord blood, using the blood to transplant stem cells, and later by out-licensing products.

But that income was tiny compared to the cost of developing its drugs. Improbably, it managed to attract enough investors to keep going and growing.

That investment is now starting to pay off. Cartistem is just one of three stem cell products approved for sale in South Korea, and Medipost might be the only public company in the country with global ambitions.

"There are not many companies that can deal with global development in the pharmerging market," said Jay Lee, a senior director at Medipost, speaking at a conference in South Korea last month.

The "pharmerging" markets are the emerging markets for pharmaceutical products. China is possibly the biggest, but there are quite a few of them in the region including South Korea and much of the Association of Southeast Asian Nations.

Even Japan, despite its large economy, is considered an emerging market in some ways because it is often years before drugs developed elsewhere make their way down to patients there due to conservative regulations.

But much is changing in the region, particularly in South Korea and Japan. Both countries are embracing often-controversial research into regenerative medicine, including stem cells.

"There is an exceptional example of a new approach in Japan. They are looking very much, as in South Korea, to develop the stem cell space," says Dianne Jackson-Matthews, an Australia-based director at ERA Consulting Group.

For the time being, government support is driving the growth of this particular industry. Private or institutional investors are not yet convinced that taking a risk on a company developing a drug using science few people understand is worthwhile.

Stem cells offer ray of hope for healthy future

Stem cells offer ray of hope for healthy future

 Stem Cell Industrial Park under construction in Wenjiang  Medical experts call for effective stem cell treatment regulation

Previous Page 1 2 3 Next Page

Hot Topics

Editor's Picks
...
...
主站蜘蛛池模板: 日本中文字幕不卡 | 精品久久久久久中文字幕 | 日韩激情在线 | 69精品人人 | 成人激情av | 欧美日韩中文字幕在线视频 | 天天爱天天操 | 亚洲欧美在线一区 | 中文字幕偷拍 | 天堂а√在线中文在线鲁大师 | 欧美三级网| 亚洲超碰在线 | 国产一区免费在线观看 | 天天夜夜人人 | 在线观看黄网站 | 国产精品久久久亚洲 | 天天躁日日躁狠狠躁 | 久久久伊人网 | 成年人在线视频免费观看 | 日韩三级一区二区三区 | 丁香九月激情 | 欧美一级二级三级视频 | 四虎影| 国产欧美一区二区精品性色超碰 | 在线你懂的 | 日本久久视频 | 韩国中文字幕hd久久精品 | www.亚洲成人 | 在线视频天堂 | 欧美另类专区 | 成年人视频网 | 国产一区 | 999热视频| 欧美在线三区 | 久久9精品 | 日韩一级一区 | 久久久久久穴 | 五月婷婷一区二区三区 | 久久中文在线 | 99精品欧美一区二区 | 成人一区二区在线观看 |